Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.

Sangtani A, Wang C, Weaver A, Hoppman NL, Kerr SE, Abyzov A, Shridhar V, Staub J, Kocher JA, Voss JS, Podratz KC, Wentzensen N, Kisiel JB, Sherman ME, Bakkum-Gamez JN.

Gynecol Oncol. 2019 Nov 28. pii: S0090-8258(19)31679-8. doi: 10.1016/j.ygyno.2019.11.028. [Epub ahead of print]

PMID:
31787246
2.

Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.

Redwood DG, Blake ID, Provost EM, Kisiel JB, Sacco FD, Ahlquist DA.

J Prim Care Community Health. 2019 Jan-Dec;10:2150132719884295. doi: 10.1177/2150132719884295.

3.

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.

Qin Y, Wu CW, Taylor WR, Sawas T, Burger KN, Mahoney DW, Sun Z, Yab TC, Lidgard GP, Allawi HT, Buttar NS, Smyrk TC, Iyer PG, Katzka DA, Ahlquist DA, Kisiel JB.

Clin Cancer Res. 2019 Sep 16. doi: 10.1158/1078-0432.CCR-19-0740. [Epub ahead of print]

PMID:
31527170
4.

Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.

Sinicrope FA, Velamala PR, Song LMWK, Viggiano TR, Bruining DH, Rajan E, Gostout CJ, Kraichely RE, Buttar NS, Schroeder KW, Kisiel JB, Larson MV, Sweetser SR, Sedlack RR, Sinicrope SN, Richmond E, Umar A, Della'Zanna G, Noaeill JS, Meyers JP, Foster NR.

Cancer Prev Res (Phila). 2019 Nov;12(11):821-830. doi: 10.1158/1940-6207.CAPR-19-0167. Epub 2019 Sep 4.

PMID:
31484660
5.

Low Incidence of Aerodigestive Cancers in Patients With Negative Results From Colonoscopies, Regardless of Findings From Multitarget Stool DNA Tests.

Berger BM, Kisiel JB, Imperiale TF, Geenen DJ, Heigh RI, Mahoney DW, Hilsden RJ.

Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30846-8. doi: 10.1016/j.cgh.2019.07.057. [Epub ahead of print]

6.

The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis.

Aniwan S, Bruining DH, Park SH, Al-Bawardy B, Kane SV, Coelho Prabhu N, Kisiel JB, Raffals LE, Papadakis KA, Pardi DS, Tremaine WJ, Loftus EV Jr.

J Clin Med. 2019 Aug 5;8(8). pii: E1171. doi: 10.3390/jcm8081171.

7.

Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.

Majumder S, Raimondo M, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Devens ME, Mahoney DW, Smyrk TC, Pannala R, Chari ST, Vege SS, Topazian MD, Petersen BT, Levy MJ, Rajan E, Gleeson FC, Dayyeh BA, Nguyen CC, Faigel DO, Woodward TA, Wallace MB, Petersen G, Allawi HT, Lidgard GP, Kisiel JB, Ahlquist DA.

Clin Gastroenterol Hepatol. 2019 Jul 16. pii: S1542-3565(19)30750-5. doi: 10.1016/j.cgh.2019.07.017. [Epub ahead of print]

PMID:
31323382
8.

Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.

Majumder S, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Mahoney DW, Aslanian HR, Fernández-Del Castillo C, Doyle LA, Farrell JJ, Fisher WE, Lee LS, Lee YN, Park W, Rodrigues C, Gould Rothberg BE, Salem RR, Simeone DM, Urs S, Van Buren G, Smyrk TC, Allawi HT, Lidgard GP, Raimondo M, Chari ST, Kendrick ML, Kisiel JB, Topazian MD, Ahlquist DA.

Am J Gastroenterol. 2019 Sep;114(9):1539-1549. doi: 10.14309/ajg.0000000000000284.

PMID:
31306149
9.

Reply.

Kisiel JB, Mahoney DW, Taylor WR, Klepp P.

Clin Gastroenterol Hepatol. 2019 Jul 4. pii: S1542-3565(19)30729-3. doi: 10.1016/j.cgh.2019.06.038. [Epub ahead of print] No abstract available.

PMID:
31279948
10.

Circulating Tumor DNA and Hepatocellular Carcinoma.

Yang JD, Liu MC, Kisiel JB.

Semin Liver Dis. 2019 Nov;39(4):452-462. doi: 10.1055/s-0039-1688503. Epub 2019 Jun 21.

PMID:
31226727
11.

Response to "Colorectal Cancer Screening by Stool DNA Testing and Patient Emotional Health".

Eckmann JD, Kisiel JB.

Am J Gastroenterol. 2019 May;114(5):829-830. doi: 10.14309/ajg.0000000000000218. No abstract available.

PMID:
30950841
12.

Increasing rates of cancer screening.

Kisiel JB, Parks P.

Am J Manag Care. 2018 Dec;24(13 Spec No.):SP586-SP588. No abstract available.

13.

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.

Kisiel JB, Dukek BA, V S R Kanipakam R, Ghoz HM, Yab TC, Berger CK, Taylor WR, Foote PH, Giama NH, Onyirioha K, Abdallah MA, Burger KN, Slettedahl SW, Mahoney DW, Smyrk TC, Lewis JT, Giakoumopoulos M, Allawi HT, Lidgard GP, Roberts LR, Ahlquist DA.

Hepatology. 2019 Mar;69(3):1180-1192. doi: 10.1002/hep.30244. Epub 2019 Feb 5.

PMID:
30168613
14.

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.

Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium.

Gastroenterology. 2018 Dec;155(6):1720-1728.e4. doi: 10.1053/j.gastro.2018.08.036. Epub 2018 Aug 27.

15.

Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.

Anderson BW, Suh YS, Choi B, Lee HJ, Yab TC, Taylor WR, Dukek BA, Berger CK, Cao X, Foote PH, Devens ME, Boardman LA, Kisiel JB, Mahoney DW, Slettedahl SW, Allawi HT, Lidgard GP, Smyrk TC, Yang HK, Ahlquist DA.

Clin Cancer Res. 2018 Nov 15;24(22):5724-5734. doi: 10.1158/1078-0432.CCR-17-3364. Epub 2018 May 29.

16.

A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia.

Wu CW, Evans JM, Huang S, Mahoney DW, Dukek BA, Taylor WR, Yab TC, Smyrk TC, Jen J, Kisiel JB, Ahlquist DA.

BMC Genomics. 2018 May 25;19(1):401. doi: 10.1186/s12864-018-4794-7.

17.

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement.

Hansel SL, McCurdy JD, Barlow JM, Fidler J, Fletcher JG, Becker B, Prabhu NC, Faubion WA, Hanson KA, Kane SV, Kisiel JB, Loftus EV Jr, Papadakis KA, Pardi DS, Raffals LE, Schoenoff S, Tremaine WJ, Bruining DH.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1582-1588. doi: 10.1093/ibd/izy050.

PMID:
29788055
18.

Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.

Kisiel JB, Klepp P, Allawi HT, Taylor WR, Giakoumopoulos M, Sander T, Yab TC, Moum BA, Lidgard GP, Brackmann S, Mahoney DW, Roseth A, Ahlquist DA.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):914-921.e5. doi: 10.1016/j.cgh.2018.05.004. Epub 2018 May 15.

PMID:
29775793
19.

Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.

Klepp P, Kisiel JB, Småstuen MC, Røseth A, Andersen SN, Vatn MH, Ahlquist DA, Moum BA, Brackmann S.

Scand J Gastroenterol. 2018 Mar;53(3):273-278. doi: 10.1080/00365521.2018.1424935. Epub 2018 Jan 9.

PMID:
29313389
20.

Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis.

Yang JD, Mannalithara A, Piscitello AJ, Kisiel JB, Gores GJ, Roberts LR, Kim WR.

Hepatology. 2018 Jul;68(1):78-88. doi: 10.1002/hep.29594. Epub 2018 May 9.

21.

Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient Sample.

Bazerbachi F, Sawas T, Vargas EJ, Haffar S, Deepak P, Kisiel JB, Loftus EV Jr, Abu Dayyeh BK.

Obes Surg. 2018 Apr;28(4):1007-1014. doi: 10.1007/s11695-017-2955-4.

PMID:
29019151
22.

Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease.

Garg SK, Velayos FS, Kisiel JB.

Gastroenterol Clin North Am. 2017 Sep;46(3):515-529. doi: 10.1016/j.gtc.2017.05.006. Review.

PMID:
28838412
23.

Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.

Wu CW, Cao X, Berger CK, Foote PH, Mahoney DW, Simonson JA, Anderson BW, Yab TC, Taylor WR, Boardman LA, Kisiel JB, Ahlquist DA.

Dig Dis Sci. 2017 Aug;62(8):1985-1994. doi: 10.1007/s10620-017-4627-6. Epub 2017 Jun 28.

24.

Colorectal cancer is increased in chronic liver diseases: Is surveillance the answer?

Kisiel JB, Talwalkar JA.

Gastrointest Endosc. 2017 Jul;86(1):105-106. doi: 10.1016/j.gie.2017.01.021. No abstract available.

PMID:
28610852
25.

Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.

Finney Rutten LJ, Jacobson RM, Wilson PM, Jacobson DJ, Fan C, Kisiel JB, Sweetser S, Tulledge-Scheitel SM, St Sauver JL.

Mayo Clin Proc. 2017 May;92(5):726-733. doi: 10.1016/j.mayocp.2017.01.019.

26.

Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study.

Cotter TG, Burger KN, Devens ME, Simonson JA, Lowrie KL, Heigh RI, Mahoney DW, Johnson DH, Ahlquist DA, Kisiel JB.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):614-621. doi: 10.1158/1055-9965.EPI-16-0800. Epub 2016 Dec 20.

27.

Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening.

Johnson DH, Kisiel JB, Burger KN, Mahoney DW, Devens ME, Ahlquist DA, Sweetser S.

Gastrointest Endosc. 2017 Mar;85(3):657-665.e1. doi: 10.1016/j.gie.2016.11.012. Epub 2016 Nov 21.

28.

Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.

Kisiel JB, Konijeti GG, Piscitello AJ, Chandra T, Goss TF, Ahlquist DA, Farraye FA, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2016 Dec;14(12):1778-1787.e8. doi: 10.1016/j.cgh.2016.07.018. Epub 2016 Jul 25. Erratum in: Clin Gastroenterol Hepatol. 2017 Apr;15(4):609.

29.

A Hazard of Outdoor Grilling.

Ramos GP, Sweetser S, Kisiel JB.

Gastroenterology. 2016 Jul;151(1):e20-1. doi: 10.1053/j.gastro.2016.03.045. Epub 2016 May 28. No abstract available.

PMID:
27243640
30.

DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.

Johnson DH, Taylor WR, Aboelsoud MM, Foote PH, Yab TC, Cao X, Smyrk TC, Loftus EV Jr, Mahoney DW, Ahlquist DA, Kisiel JB.

Inflamm Bowel Dis. 2016 Jul;22(7):1559-67. doi: 10.1097/MIB.0000000000000795.

31.

Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis.

Kisiel JB, Loftus EV.

Am J Gastroenterol. 2015 Oct;110(10):1473-4. doi: 10.1038/ajg.2015.315.

32.

Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy.

Deepak P, Hanson GJ, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Wong Kee Song LM, Harmsen WS, Loftus EV Jr, Bruining DH.

Gastrointest Endosc. 2016 May;83(5):1005-12. doi: 10.1016/j.gie.2015.09.021. Epub 2015 Sep 25.

PMID:
26408903
33.

Endoscopic overestimation of colorectal polyp size.

Anderson BW, Smyrk TC, Anderson KS, Mahoney DW, Devens ME, Sweetser SR, Kisiel JB, Ahlquist DA.

Gastrointest Endosc. 2016 Jan;83(1):201-8. doi: 10.1016/j.gie.2015.06.058. Epub 2015 Aug 28.

PMID:
26318830
34.

New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.

Kisiel JB, Raimondo M, Taylor WR, Yab TC, Mahoney DW, Sun Z, Middha S, Baheti S, Zou H, Smyrk TC, Boardman LA, Petersen GM, Ahlquist DA.

Clin Cancer Res. 2015 Oct 1;21(19):4473-81. doi: 10.1158/1078-0432.CCR-14-2469. Epub 2015 May 28.

35.

Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.

Kisiel JB, Li J, Zou H, Oseini AM, Strauss BB, Gulaid KH, Moser CD, Aderca I, Ahlquist DA, Roberts LR, Shire AM.

J Mol Biomark Diagn. 2013 Aug 3;4(145):1000145.

36.

Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance.

Kisiel JB, Yab TC, Taylor WR, Mahoney DW, Ahlquist DA.

Dig Dis Sci. 2014 Aug;59(8):1764-7. doi: 10.1007/s10620-014-3265-5. Epub 2014 Jul 4.

37.

Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis.

Johnson DH, Khanna S, Smyrk TC, Loftus EV Jr, Anderson KS, Mahoney DW, Ahlquist DA, Kisiel JB.

Aliment Pharmacol Ther. 2014 Jun;39(12):1408-17. doi: 10.1111/apt.12774. Epub 2014 Apr 30.

38.

Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view.

Kisiel JB, Ahlquist DA.

Therap Adv Gastroenterol. 2013 Sep;6(5):371-80. doi: 10.1177/1756283X13487941.

39.

Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

McCurdy JD, Loftus EV Jr, Tremaine WJ, Smyrk TC, Bruining DH, Pardi DS, Raffals LE, Kisiel JB, Coelho-Prabhu N, Kane SV, Faubion WA, Papadakis KA.

Inflamm Bowel Dis. 2013 Oct;19(11):2394-9. doi: 10.1097/MIB.0b013e3182a52553.

40.

Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.

Kisiel JB, Garrity-Park MM, Taylor WR, Smyrk TC, Ahlquist DA.

Inflamm Bowel Dis. 2013 Sep;19(10):2079-83. doi: 10.1097/MIB.0b013e31829b3f4d.

41.

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Kisiel JB, Yab TC, Nazer Hussain FT, Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk TC, Itzkowitz SH, Rubin DT, Zou H, Mahoney DW, Ahlquist DA.

Aliment Pharmacol Ther. 2013 Mar;37(5):546-54. doi: 10.1111/apt.12218. Epub 2013 Jan 24.

42.

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.

Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, Ahlquist DA.

Cancer. 2012 May 15;118(10):2623-31. doi: 10.1002/cncr.26558. Epub 2011 Sep 22.

43.

Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.

Kisiel JB, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ.

Inflamm Bowel Dis. 2012 Feb;18(2):226-35. doi: 10.1002/ibd.21687. Epub 2011 Mar 17.

PMID:
21416564
44.

Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.

Kisiel JB, Ahlquist DA.

J Clin Gastroenterol. 2011 Apr;45(4):301-8. doi: 10.1097/MCG.0b013e3181f0f028. Review.

PMID:
20856138
45.

Resident physicians' perspectives on effective outpatient teaching: a qualitative study.

Kisiel JB, Bundrick JB, Beckman TJ.

Adv Health Sci Educ Theory Pract. 2010 Aug;15(3):357-68. doi: 10.1007/s10459-009-9202-2. Epub 2009 Oct 2.

PMID:
19798583
46.

Computed tomographic colonography and high-risk adenomas: a gap in the guidelines?

Kisiel JB, Bruining DH, Fletcher JG, Limburg PJ.

Gastroenterology. 2009 Jun;136(7):2395-6; discussion 2396-7. doi: 10.1053/j.gastro.2009.04.038. Epub 2009 May 3. No abstract available.

PMID:
19406132
47.

68-year-old man with fever, back pain, and mental status changes.

Kisiel JB, McDonald FS.

Mayo Clin Proc. 2005 Aug;80(8):1069-72. No abstract available.

PMID:
16092587
48.

Supplemental Content

Loading ...
Support Center